The Valeo family of ceramic spinal intervertebral spacers is intended to aid in surgical correction and stabilization of the thoracolumbar spine. These implants are designed to restore the biomechanical integrity of the anterior, middle and posterior spine, even in the absence of fusion, for a prolonged period of time, the company said.
The Valeo family of spacers provides new functionalities compared to competing devices currently on the market and is believed to be the first family of silicon nitride ceramic implants available for spinal use in the world.
Ashok Khandkar, CEO of Amedica, said: “Obtaining the CE mark for our Valeo ceramic spinal spacers expands our ability to bring our portfolio of spinal implant products to important markets in Europe, Asia and other regions of the world. This achievement gives us the ability to begin to educate and train physicians in Europe and other foreign markets so that more patients can benefit from our innovative implants.”